Astrana Health, Inc. (ASTH)
(Real Time Quote from BATS)
$39.12 USD
+0.23 (0.59%)
Updated May 13, 2024 01:06 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Astrana Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 57.85 | 50.53 | 49.29 | 122.32 | 17.67 |
Depreciation/Amortization & Depletion | 18.81 | 18.48 | 18.60 | 19.70 | 20.75 |
Net Change from Assets/Liabilities | -16.21 | -9.58 | -20.12 | 10.81 | -22.77 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.77 | 22.70 | 22.57 | -106.67 | -1.98 |
Net Cash From Operating Activities | 68.23 | 82.13 | 70.34 | 46.16 | 13.67 |
Property & Equipment | -28.53 | -22.94 | -19.22 | -1.11 | -1.04 |
Acquisition/ Disposition of Subsidiaries | -6.51 | -16.35 | -2.59 | -11.35 | -49.40 |
Investments | -6.68 | 28.11 | 32.37 | 91.61 | -119.00 |
Other Investing Activities | -23.80 | 4.07 | 5.98 | 16.36 | -11.19 |
Net Cash from Investing Activities | -65.52 | -7.11 | 16.54 | 95.49 | -180.63 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -8.67 | -0.62 | 43.46 | 10.27 | -3.69 |
Issuance (Repayment) of Debt | 79.17 | -0.83 | 0.16 | -9.61 | 194.88 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -58.13 | 0.00 | 39.60 |
Payment of Dividends & Other Distributions | -62.15 | -18.64 | -32.51 | -52.36 | -61.72 |
Other Financing Activities | -4.93 | 0.00 | -0.73 | 0.00 | -5.74 |
Net Cash from Financing Activities | 3.42 | -20.09 | -47.75 | -51.70 | 163.33 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 6.13 | 54.93 | 39.13 | 89.96 | -3.63 |
Cash at Beginning of Period | 288.03 | 233.10 | 193.97 | 104.01 | 107.64 |
Cash at End of Period | 294.15 | 288.03 | 233.10 | 193.97 | 104.01 |
Diluted Net EPS | 1.29 | 1.08 | 1.63 | 1.01 | 0.39 |
Fiscal Year End for Astrana Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 16.86 | 57.85 | 57.94 | 29.97 | 14.31 |
Depreciation/Amortization & Depletion | 5.55 | 18.81 | 13.56 | 9.02 | 4.53 |
Net Change from Assets/Liabilities | -23.16 | -16.21 | -34.77 | -9.70 | -19.26 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.72 | 7.77 | 12.20 | 4.24 | 8.14 |
Net Cash From Operating Activities | 5.98 | 68.23 | 48.93 | 33.52 | 7.72 |
Property & Equipment | -0.37 | -28.53 | -21.47 | -17.37 | -14.85 |
Acquisition/ Disposition of Subsidiaries | -50.65 | -6.51 | -4.67 | 0.35 | 0.00 |
Investments | -0.03 | -6.68 | -5.15 | -4.35 | -1.33 |
Other Investing Activities | -19.99 | -23.80 | -22.80 | 2.14 | 2.14 |
Net Cash from Investing Activities | -71.04 | -65.52 | -54.10 | -19.22 | -14.04 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | -8.67 | -8.44 | -8.29 | -8.29 |
Issuance (Repayment) of Debt | 106.32 | 79.17 | 2.18 | 1.12 | 1.31 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.06 | -62.15 | -2.27 | -0.84 | -0.12 |
Other Financing Activities | -0.03 | -4.93 | -0.05 | -0.05 | 0.00 |
Net Cash from Financing Activities | 106.35 | 3.42 | -8.57 | -8.06 | -7.10 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 41.29 | 6.13 | -13.74 | 6.24 | -13.41 |
Cash at Beginning of Period | 294.15 | 288.03 | 288.03 | 288.03 | 288.03 |
Cash at End of Period | 335.44 | 294.15 | 274.29 | 294.27 | 274.61 |
Diluted Net EPS | 0.31 | 0.23 | 0.47 | 0.28 | 0.31 |